India’s private hospital sector is poised for another year of robust expansion, with revenues expected to grow 14–15% in fiscal 2027, marking the fifth consecutive year of double-digit growth, according to Crisil Ratings.
The growth trajectory will be underpinned by sustained healthy occupancy levels, steady improvements in realisations and accelerated bed additions across leading hospital chains. New facilities are also stabilising faster than in previous cycles, strengthening operational performance and cash flow visibility.
Rising Realisations Drive Momentum
Average Revenue Per Occupied Bed (ARPOB) is projected to increase 5–7% to approximately ₹52,200 next fiscal for the portfolio analysed by Crisil Ratings, which covers 98 private hospitals accounting for nearly two-thirds of the sector’s revenue. The sector’s revenue stood at ₹78,500 crore in fiscal 2025.
The improvement in ARPOB is being driven by a rising share of complex, high-value treatments across key specialties such as cardiology, oncology, neurology, gastroenterology and orthopaedics. The share of CONGO specialties has increased to 62% in fiscal 2025 from 59% pre-pandemic, reflecting a sustained shift toward advanced procedures.
Crisil Ratings senior director Anuj Sethi noted that higher complexity treatments, coupled with an improving share of insured patients, are supporting both volumes and pricing. He added that policy measures such as the GST exemption on health insurance premiums are likely to encourage insurance uptake, further enabling hospitalisation demand. Despite significant capacity additions, occupancy levels are expected to remain stable at around 65%.
Margins Hold Firm Amid Expansion
Healthy demand and operating leverage are projected to keep operating margins stable at 20–21%, even as hospital chains continue to invest aggressively in expansion. Notably, new facilities are achieving breakeven within 12–18 months compared with three to four years earlier, reflecting better planning, stronger brand recall and faster patient acquisition.
Expansion strategies have evolved into a calibrated mix of brownfield additions, greenfield projects and acquisitions of operational assets. This diversified approach has enabled quicker stabilisation and limited the drag from initial ramp-up costs.
Between fiscal 2024 and 2026, large private hospital players completed acquisitions worth ₹11,000 crore, adding approximately 4,300 beds. While these transactions were executed at an estimated 2.2x valuation premium for operational assets, they were funded through a prudent blend of internal accruals, equity and moderate borrowings, thereby containing balance sheet risks.
Organic Expansion Accelerates
Organic bed additions are set to scale up meaningfully, with over 10,000 beds expected to become operational across the current and next fiscal — including around 6,000 beds this year alone. This is more than double the roughly 4,500 beds added in the preceding two years, underscoring the elevated expansion pipeline.
Crisil Ratings director Poonam Upadhyay highlighted that the expansion mix has shifted from 60:40 (organic:inorganic) to 80:20 as large acquisition opportunities have become limited. Players are increasingly entering new geographies through selective acquisitions and then scaling up organically. Expansion remains concentrated in metros, high-ARPOB clusters and select Tier-2 cities where advanced healthcare infrastructure and specialist services remain underpenetrated.
Credit Profiles Remain Healthy
Despite elevated capital expenditure — expected at approximately ₹13,000 crore in fiscal 2027 compared with ₹12,000 crore in the current fiscal — reliance on external debt is projected to remain limited. Strong internal accruals are expected to fund a substantial portion of investments. As a result, key credit metrics are likely to stay comfortable, with interest coverage around six times and debt-to-EBITDA at roughly 1.7 times, broadly in line with current levels.